|
|
Volumn 28, Issue 6-7, 2005, Pages 311-312
|
|
Lessons learned from the edrecolomab story: how a checkered past became a checkered flag for monoclonal antibodies in colorectal cancer therapy.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EDRECOLOMAB;
MONOCLONAL ANTIBODY;
CLINICAL TRIAL;
COLORECTAL TUMOR;
EDITORIAL;
EUROPE;
EVIDENCE BASED MEDICINE;
HUMAN;
METHODOLOGY;
RETROSPECTIVE STUDY;
TREATMENT OUTCOME;
UNITED STATES;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
COLORECTAL NEOPLASMS;
EUROPE;
EVIDENCE-BASED MEDICINE;
HUMANS;
RETROSPECTIVE STUDIES;
TREATMENT OUTCOME;
UNITED STATES;
MLCS;
MLOWN;
|
|
EID: 23844452159
PISSN: 0378584X
EISSN: None
Source Type: Journal
DOI: 10.1159/000085570 Document Type: Editorial |
|
Times cited : (9)
|
|
References (0)
|
